Skip to main content
editorial
. 2015 Jan 30;6(7):4551–4552. doi: 10.18632/oncotarget.3114

Figure 1.

Figure 1

By favoring senescence instead of apoptosis, the BCL-XL/MCL-1 survival pathway facilitates the emergence of resistant cells